Microsoft Word[removed]Advisory New Anticoagulants.docx

First Page		Document Content
Date: 2014-10-09 18:27:54 Anticoagulants Heparins Coagulation system Dabigatran Rivaroxaban Factor X Warfarin Stroke Deep vein thrombosis Chemistry Organic chemistry Hematology		Microsoft Word[removed]Advisory New Anticoagulants.docx Add to Reading List Source URL: www.mass.gov Download Document from Source Website File Size: 180,13 KB Share Document on Facebook

	Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio DocID: 1qfnw - View Document
	warfarin isotype genetic, warfarin first affects which factor new alternative for warfarin warfarin and coagulation pathway. warfarin substitutes provac warfarin 24 mg. validated methods for warfarin sodium medical warfa DocID: 1pADC - View Document
	Atrial Fibrillation (AFib) Treatment Adherence Following your treatment plan will reduce your risk of AFib-related stroke. it can enter the bloodstream and cause a stroke. A stroke means DocID: 1pjDF - View Document
	SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Venous Thromboembolism (VTE) Prevention Following Surgery Pharmaceutical Services Department of Health and Community Serv DocID: 1p0MX - View Document
	Guideline Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideli DocID: 1ofpB - View Document